Home/Protocols/NAD+
Protocol Reference
Human trial data

NAD+ protocol

NAD+ (nicotinamide adenine dinucleotide). Dosing on this page comes from a published human trial or an approved product label, cited below.

Category
Longevity & Cellular
Common vials
500 mg
Half-life
Rapidly metabolised
Route in the literature
Intravenous in the study literature
Evidence level
Human trial data

How NAD+ works

A coenzyme central to redox reactions and a substrate for sirtuins and PARPs. Tissue NAD+ falls with age, which is the basis of interest in restoring it — though whether infused NAD+ enters cells intact or is broken down first and salvaged is genuinely contested.

NAD+ dosing schedule

From a pharmacokinetic study of intravenous NAD+ in healthy men, which is the clearest published human dosing for infused NAD+ itself. Note it was designed to measure what happens to the molecule, not to demonstrate a clinical benefit.

PhaseAmountFrequencyNotes
Pilot study750 mgSingle infusion over 6 hours, intravenousThe amount and rate used in the published human PK study.

Study length: Single 6-hour infusion in the pilot study.

Source for this schedule: Grant R et al., "A Pilot Study Investigating Changes in the Human Plasma and Urine NAD+ Metabolome During a 6 Hour Intravenous Infusion of NAD+", Front Aging Neurosci 2019. This reproduces what was administered in that work. It is reference information about a study, not a recommendation, and the trial population, monitoring and endpoints are part of what made it a protocol.

Reconstitution and measurement

This part is arithmetic and does not depend on the evidence level. Concentration is vial size divided by the bacteriostatic water you add. Draw volume is your target amount divided by that concentration. Units are draw volume times 100, because a U-100 syringe reads 100 units per millilitre. Common vials for NAD+: 500 mg.

Open the NAD+ calculator → Unit converter

Storage and stability

Dry powder
Cold, dark and dry. Lyophilized peptide is the stable form — keep it that way until you intend to use it.
After reconstitution
Refrigerate at 2–8 °C, protect from light, and plan around a limited window. Do not freeze a reconstituted vial — freeze-thaw damages peptides.
Mixing
Run bacteriostatic water down the inside wall of the vial rather than onto the powder, then swirl. Never shake.
Inspect before use
A clear solution is expected. Cloudiness or particles mean discard, not use.

Full storage guide → · Cloudy solution?

Reported effects

  • Infusion rate is the practical constraint most often described — rapid administration is associated with flushing, chest tightness and nausea, which is why infusions are given slowly.
  • The pilot study found most of the infused NAD+ appeared in urine as metabolites, raising real questions about how much reaches cells intact.
  • Subcutaneous NAD+ has no comparable published pharmacokinetic study.

Sourcing NAD+

Whatever you are working with, the documentation matters more than the price. Ask for a batch certificate of analysis whose lot number matches the vial you actually receive — a COA for a different batch tells you nothing about yours.

NAD+ at Summit Research Supply → Grade a COA first

Summit is the supplier we feature and an affiliate link. Our COA checklist applies the same way to any vendor.

For laboratory research use only. This page documents what the published literature reports about NAD+. It is not a recommendation, not a treatment plan, and not medical advice. Compounds referenced are sold strictly as research chemicals and are not for human or veterinary use. Some supplier links are affiliate links and may earn us a commission. This never affects tier placement or review conclusions.
Summit Research Supply
Summit Research Supply — COA-verified research peptidesThird-party tested · U.S. fulfillment · new researchers save 10%
Shop →